July - Aug 20186Advanced technologies have set foot in almost every industry that we know of and medicine is no different. However, owing to the fact that there is no end to diseases, the pharmaceutical industry perceives the need to perpetually evolve and enhance medical diagnoses. One such segment of medicine, the in-vitro diagnostics (IVD) market is witnessing a significant paradigm shift with the influx of modern technologies, which are constantly refining the entire spectrum of offerings that IVD brings to the table. Rendering traditional diagnostics passé, next-generation IVD is working its way up to the gene level. As per MarketsandMarkets, by the year 2023, the global IVD market is estimated to reach $ 87.93 Bn, at a CAGR of 5.2 percent over the forecast period. Propelling the growth of the IVD market are several factors: inclination of patients toward point-of-care (POC) testing, demand for accelerated results, and the unique needs of the geriatrics, to name a few. Rather than limiting patients in a typical hospital or central laboratory, IVD is facilitating them with a POC testing modality that enables testing in alternate-care centers, outpatient clinics, or any place that is convenient for the patients. IVD is boosting the speed of diagnoses in a cost-effective way to cater to the diverse needs of people and bettering treatments in the process. Besides, with a growing aging population and their special care requirements, IVD has surfaced as the much-needed breakthrough that has brought forth a fundamental re-modification in patient care delivery. To deliver cost-competitive IVD services, healthcare organizations are constantly examining the scope of cutting-edge technologies such as internet of things (IoT) and data analytics. IoT tools play an integral role in maintaining the health of IVD devices by remotely managing and monitoring them, analyzing their usage and supply consumption. With data analytics, evaluating operational data is becoming increasingly easier, expediting accurate prediction of potential downtime of deployed IVD solutions in any clinical setting. Needless to say, the IVD landscape is transforming healthcare in unprecedented ways and with this special edition, let's have a look at how new technologies are shaping up the IVD industry.Copyright © 2018 ValleyMedia Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.JULY - AUGUST - 2018VOLUME 01 - 05IN-VITRO DIAGNOSTICS SPECIALContact UsPhone:510 230 0396 Fax:510-894-8405Emailsales@medicaltechoutlook.comeditor@medicaltechoutlook.commarketing@medicaltechoutlook.comManaging EditorAlex D'souzaEditorial StaffSalesJoe Philip Khyati DubalLaura PintoMatthew JacobMerlin WatsonSarah FernandesVisualizerAR RamjithEric Thomaseric@medicaltechoutlook.com510.722.8394Alex D'souzaManaging Editoreditor@Medicaltechoutlook.comPropelling Innovation in Diagnostics*Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffEditorialPublished by ValleyMedia Inc. To subscribe to MedicalTech OutlookVisit www.Medicaltechoutlook.com
< Page 5 | Page 7 >